[PLX] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
28-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -80.27%
YoY- -10.82%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue -11,195 1,384 1,122 48 2,362 1,176 388 -
PBT -12,419 -8,469 -10,885 968 968 22,414 31,440 -
Tax -85,260 57 0 -1,741 -27,616 -20,470 -16,504 31.46%
NP 72,900 -8,469 -10,885 -9,877 -8,913 -8,528 -14,936 -
Tax Rate - - - 179.86% 2,852.89% 91.33% 52.49% -
Total Cost -84,095 9,853 12,007 9,925 11,275 9,704 15,324 -
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -651.18 -611.92 -970.14 -20,577.08 -377.35 -725.17 -3,849.48 -25.62%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS 7.31 -0.91 -1.18 -1.07 -1.01 -1.04 -1.85 -
EPS Diluted 7.31 -0.91 -1.17 -1.07 -1.01 -1.04 -1.85 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.